CN101962464B - Method for preparing calcium alginate microspheres with temperature response performance - Google Patents
Method for preparing calcium alginate microspheres with temperature response performance Download PDFInfo
- Publication number
- CN101962464B CN101962464B CN2010102923304A CN201010292330A CN101962464B CN 101962464 B CN101962464 B CN 101962464B CN 2010102923304 A CN2010102923304 A CN 2010102923304A CN 201010292330 A CN201010292330 A CN 201010292330A CN 101962464 B CN101962464 B CN 101962464B
- Authority
- CN
- China
- Prior art keywords
- temperature
- calcium alginate
- hexanolactam
- ethene hexanolactam
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000010410 calcium alginate Nutrition 0.000 title claims abstract description 18
- 239000000648 calcium alginate Substances 0.000 title claims abstract description 18
- 229960002681 calcium alginate Drugs 0.000 title claims abstract description 18
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 title claims abstract description 18
- 230000004044 response Effects 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title abstract description 10
- 239000004005 microsphere Substances 0.000 title abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 17
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 14
- 239000007864 aqueous solution Substances 0.000 claims abstract description 13
- 239000000661 sodium alginate Substances 0.000 claims abstract description 12
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 12
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 11
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000004945 emulsification Methods 0.000 claims abstract description 7
- 239000000839 emulsion Substances 0.000 claims abstract description 5
- 239000003999 initiator Substances 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 239000012153 distilled water Substances 0.000 claims abstract description 4
- 238000009775 high-speed stirring Methods 0.000 claims abstract description 3
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 16
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical group CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 claims description 3
- 238000006392 deoxygenation reaction Methods 0.000 claims description 3
- 230000008021 deposition Effects 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 238000009987 spinning Methods 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- UZIQYDXSZVYYCF-UHFFFAOYSA-N azepan-2-one;ethene Chemical compound C=C.O=C1CCCCCN1 UZIQYDXSZVYYCF-UHFFFAOYSA-N 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 abstract 1
- 239000004971 Cross linker Substances 0.000 abstract 1
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000001723 curing Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 239000011521 glass Substances 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002389 environmental scanning electron microscopy Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000004848 nephelometry Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- AEMOLEFTQBMNLQ-AZLKCVHYSA-N (2r,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-AZLKCVHYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000011806 microball Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention discloses a method for preparing calcium alginate microspheres with temperature response performance, which comprises the following steps of: fully dissolving selected amount of N-vinylcaprolactam and the like and sodium alginate in water, preparing into aqueous solution, adding an initiator, uniformly mixing for deoxidation, and performing stirring reaction at constant temperature for 3 to 6 hours; cooling the reaction liquid obtained in the last step to room temperature, slowly adding into an oil phase in which an emulsifier 1 is dissolved for emulsification, adding into aqueous solution with an emulsifier 2 for emulsification, dripping a cross-linker with high-speed stirring, stirring, and curing; and precipitating the emulsion obtained in the last step by using absolute ethyl alcohol, performing centrifugal separation, washing with absolute ethyl alcohol and distilled water respectively, and performing freeze drying to obtain the finished product. The calcium alginate microspheres have certain temperature response performance, and the response temperature is near the physiological temperature; and the calcium alginate microspheres have good biocompatibility and biodegradability, and have wide application prospect in the field of biomedicines, particularly in the aspect of control release of medicines.
Description
Technical field
The invention belongs to the material technology field, relate to a kind of preparation method, specifically relate to a kind of preparation method with calcium alginate compounded microballoon of temperature response performance with microballoon of temperature response performance.
Background technology
Study new and effective drug release material and control delivery; Be the human main path that improves drug release pattern, reduction toxic side effect, strengthens absorption and result of treatment of exploring always, attracted very big interest from chemistry, materialogy and pharmaceutical field researchist.
Lalgine is the natural polysaccharide polymkeric substance from extracting algae; Be a kind of by (1 → 4) α-L-guluronic acid and (1 → 4) beta-D-mannuronic acid dependence 1; The copolymerized macromolecule that the 4-glycosidic link connects to form is nontoxic, have excellent biological compatibility and degradability, cheap; Have a good application prospect at biomedical sector, especially receive certain concern as drug delivery system (DDS).The researchist successively adopts W/O emulsification-ionic cross-linking, micro-fluidic technologies, dropping method etc. to prepare the calcium alginate microsphere drug delivery system both at home and abroad.In order to strengthen the function of Lalgine pharmaceutical carrier, the researchist is also compound with the natural polymer (like soybean protein isolate, chitosan) of Lalgine and other biologically active.
Lalgine DDS exists significantly not enough: most of Lalgine DDS just have certain slow releasing function to medicine, lack the sustained release ability of response physiological event (especially temperature variation) but at present.
Temperature sensitivity superpolymer with low critical transformation temperature (LCST) is one type of superpolymer with special thermal property.When envrionment temperature was lower than LCST, its solvability in solution can slowly reduce along with temperature raises.In case but in temperature was elevated near the LCST very among a small circle, its solvability can reduce suddenly, heat sink falling occur, and this variation is a reversible.In this type superpolymer the most representative be gather (N-NSC 11448) (PNIPAm) with Vilaterm hexanolactam (PVCL).Because the LCST of these two kinds of polymkeric substance is in the physiological temp scope (30～40 ℃), make their serial superpolymer in biological and medical material, extremely application prospects arranged.Compare with PNIPAm, PVCL has better biocompatibility and lower toxicity, but less with application about its research.
Summary of the invention
The object of the present invention is to provide a kind of preparation method with calcium alginate compounded microballoon of temperature response performance, the product that adopts this method to obtain not only has excellent biological compatibility, biodegradability, and has good temperature-responsive.
Its technical solution is:
A kind of preparation method with calcium alginate compounded microballoon of temperature response performance comprises the steps:
(1) with N-ethene hexanolactam or contain the mixture of N-ethene hexanolactam; Fully soluble in water with sodium-alginate; Be made into massfraction and be 2% the aqueous solution, wherein N-ethene hexanolactam or the massfraction that contains the mixture of N-ethene hexanolactam are 25～75% (being preferably 40～60%), and the massfraction of sodium-alginate is 25～75% (being preferably 40～60%); Add initiator; And carry out thorough mixing, dissolving, deoxygenation is then at 45～75 ℃ of (being preferably 50～60 ℃) constant temperature stirring reactions 3～6 hours (being preferably 4～5 hours);
(2) with step (1) obtain reaction solution be cooled to room temperature, slowly add and be dissolved with in the oil phase of emulsifying agent 1, the volume ratio of oil phase and reaction solution is 2: 3, emulsification 15 minutes; The aqueous solution that adds emulsifying agent 2 then, emulsification 10 minutes; Under high-speed stirring, adding 25mL dropping linking agent by every 100mL emulsion at last is the calcium ions aqueous solution, stirs, solidifies 15 minutes;
(3) emulsion that step (2) is obtained is used absolute ethyl alcohol, distilled water wash respectively again with absolute ethyl alcohol deposition, spinning, and lyophilize gets product.
In the above-mentioned steps (1); The mixture of the described N-of containing ethene hexanolactam is mixture or N-ethene hexanolactam and acrylic acid mixture of N-ethene hexanolactam and methylacrylic acid; The mixture of N-ethene hexanolactam and methylacrylic acid wherein; The quality proportioning of N-ethene hexanolactam and methylacrylic acid is 90～99: 10～1, is preferably 94～97: 6～3; N-ethene hexanolactam and acrylic acid mixture, N-ethene hexanolactam and acrylic acid quality proportioning are 90～99: 10～1, are preferably 94～97: 6～3.
In the above-mentioned steps (1), described initiator is a Diisopropyl azodicarboxylate, and consumption is 1%～5% of N-ethene hexanolactam or the mixture mole number that contains N-ethene hexanolactam, is preferably 2%; In the above-mentioned steps (2); Described oil phase is a normal hexane, and described emulsifying agent 1 is Span-85, and consumption is that 0.01～0.06g/mL (is preferably 0.03～0.05g/mL) oil phase; Described emulsifying agent 2 is Tween-85; The total mass number of using is identical with the total mass number of emulsifying agent 1 use, and during use emulsifying agent 2 being diluted to massfraction is 50% the aqueous solution, and described linking agent is that massfraction is 8% CaCl
2The aqueous solution.
In the above-mentioned steps (1), described stirring velocity is 200r/min, and described temperature of reaction is 60 ℃, and the described reaction times is 5 hours; In the above-mentioned steps (2), described stirring velocity is 1000～1400r/min, is preferably 1200～1350r/min.
The present invention has following useful technique effect:
(1) one of raw material of utilization preparation microballoon-sodium-alginate is as diffuse-aggregate stablizer; Obtain temperature sensitive property sodium-alginate/Vilaterm hexanolactam base polymer mixing solutions, safety simple to operate through original position dispersion polymerization one step of monomers such as N-ethene hexanolactam in sodium alginate aqueous solution.
(2) the calcium alginate compounded microballoon that is obtained has certain temperature-responsive and response temperature on the one hand near physiological temp; Have excellent biological compatibility and biodegradability on the other hand; In the bio-medical field, especially controlled delivery of pharmaceutical agents release aspect has wide application prospects.
Description of drawings
Below in conjunction with accompanying drawing and embodiment the present invention is described further:
Fig. 1 is that the embodiment of the invention 1 is obtained finished product is that calcium alginate compounded microballoon adheres on the slide glass, after handling through metal spraying, slide glass is placed under the ESEM (the Japanese JEOL JSM-6390LV of company type) photo of shooting.
Fig. 2 is that the embodiment of the invention 2 is obtained finished products is that calcium alginate compounded microballoon adheres on the slide glass, after handling through metal spraying, slide glass is placed under the ESEM (the Japanese JEOL JSM-6390LV of company type) photo of shooting.
Embodiment
Embodiment 1
In the 250mL there-necked flask, add 0.4g sodium-alginate, 0.8g N-ethene hexanolactam, 58.8g water; Be about 2.14% of N-ethene hexanolactam mole number 0.02g Diisopropyl azodicarboxylate is a Diisopropyl azodicarboxylate, stir, carry out thorough mixing, dissolving; Deoxygenation is as charging into nitrogen half a hour; Heat temperature raising to 60 ℃ reacted 5 hours then, and reaction process can be accompanied by that continuity stirs or intermittent the stirring.Reaction mixture is cooled to room temperature, slowly is added to 40mL and is dissolved with in the normal hexane of 2g Span-85, behind the stirring 15min, drip 2g Tween-85 (with the water dilution of 2mL), continue emulsification 10min.Drip the 25mL massfraction at last and be 8% calcium chloride water, stir and solidify 15min.With absolute ethyl alcohol deposition, spinning, use absolute ethyl alcohol, distilled water wash then respectively, lyophilize obtains finished product as shown in Figure 1.
Embodiment 2
Roughly with the method for embodiment 1, the consumption of different is sodium-alginate, N-ethene hexanolactam, Diisopropyl azodicarboxylate is respectively 0.6g, 0.6g, 0.015g, and above-mentioned Diisopropyl azodicarboxylate is about 2.12% of N-ethene hexanolactam mole number.The gained finished product is as shown in Figure 2.
Embodiment 3
Roughly with the method for embodiment 1, different is to add 0.8g sodium-alginate, 0.4gN-ethene hexanolactam, 0.01g Diisopropyl azodicarboxylate, and above-mentioned Diisopropyl azodicarboxylate is about 2.13% of N-ethene hexanolactam mole number.
Embodiment 4
Roughly with the method for embodiment 1; Different is to add 0.6g sodium-alginate, 0.57g N-ethene hexanolactam, 0.03g methylacrylic acid, 0.015g Diisopropyl azodicarboxylate, and above-mentioned Diisopropyl azodicarboxylate is about 2.08% of N-ethene hexanolactam and methacrylic acid mixture mole number.
Embodiment 5
Roughly with the method for embodiment 1, different is to add 0.6g sodium-alginate, 0.57g N-ethene hexanolactam, 0.03g vinylformic acid, 0.015g Diisopropyl azodicarboxylate, and above-mentioned Diisopropyl azodicarboxylate is 2.03% of N-ethene hexanolactam and a vinylformic acid mole number.
The calcium alginate compounded microballoon of aforesaid way preparation has temperature-responsive preferably; The volume phase transition temperature is near physiological temp, and the calcium alginate compounded microballoon phase transition temperature that the above-mentioned corresponding embodiment that utilizes 721 type spectrophotometers to record through nephelometry obtains is listed in table 1.
The phase transition temperature of the gel micro-ball that table 1 nephelometry records
| Product | Embodiment 1 | Embodiment 2 | Embodiment 3 |
| Phase transition temperature ℃ | 37.0 | 36.0 | 35.5 |
Claims (4)
1. the preparation method with calcium alginate compounded microballoon of temperature response performance is characterized in that comprising the steps:
(1) be 25～75% N-ethene hexanolactam or the mixture that contains N-ethene hexanolactam with massfraction; With massfraction be that 25～75% sodium-alginate is fully soluble in water; Be made into massfraction and be 2% the aqueous solution, add initiator, and carry out thorough mixing, dissolving; Deoxygenation is then 45～75 ℃ of constant temperature stirring reactions 3～6 hours; The mixture of the described N-of containing ethene hexanolactam is mixture or N-ethene hexanolactam and acrylic acid mixture of N-ethene hexanolactam and methylacrylic acid; The mixture of N-ethene hexanolactam and methylacrylic acid wherein, the quality proportioning of N-ethene hexanolactam and methylacrylic acid is 90～99: 10～1; N-ethene hexanolactam and acrylic acid mixture, N-ethene hexanolactam and acrylic acid quality proportioning are 90～99: 10～1;
(2) reaction solution that step (1) is obtained is cooled to room temperature, slowly adds the oil phase that is dissolved with first emulsifying agent, and the volume ratio of oil phase and reaction solution is 2: 3, emulsification 15 minutes; The aqueous solution that adds second emulsifying agent then, emulsification 10 minutes; Under high-speed stirring, adding 25mL dropping linking agent by every 100mL emulsion at last is the calcium ions aqueous solution, stirs, solidifies 15 minutes;
(3) emulsion that step (2) is obtained is used absolute ethyl alcohol, distilled water wash respectively again with absolute ethyl alcohol deposition, spinning, and lyophilize gets product.
2. the preparation method with calcium alginate compounded microballoon of temperature response performance according to claim 1; It is characterized in that: in the said step (1); Described initiator is a Diisopropyl azodicarboxylate, and consumption is 1～5% of N-ethene hexanolactam or the mixture mole number that contains N-ethene hexanolactam; In the said step (2); Described oil phase is a normal hexane, and described first emulsifying agent is Span-85, and consumption is 0.01～0.06g/mL oil phase; Described second emulsifying agent is Tween-85; The total mass number of using is identical with the total mass number of first emulsifying agent use, and during use second emulsifying agent being diluted to massfraction is 50% the aqueous solution, and described linking agent is that massfraction is 8% CaCl
2The aqueous solution.
3. the preparation method with calcium alginate compounded microballoon of temperature response performance according to claim 1; It is characterized in that: in the said step (1); Described stirring velocity is 200r/min, and described temperature of reaction is 60 ℃, and the described reaction times is 5 hours; In the said step (2), described stirring velocity is 1000～1400r/min.
4. the preparation method with calcium alginate compounded microballoon of temperature response performance according to claim 2; It is characterized in that: in the said step (1); Described stirring velocity is 200r/min, and described temperature of reaction is 60 ℃, and the described reaction times is 5 hours; In the said step (2), described stirring velocity is 1000～1400r/min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102923304A CN101962464B (en) | 2010-09-27 | 2010-09-27 | Method for preparing calcium alginate microspheres with temperature response performance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102923304A CN101962464B (en) | 2010-09-27 | 2010-09-27 | Method for preparing calcium alginate microspheres with temperature response performance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101962464A CN101962464A (en) | 2011-02-02 |
| CN101962464B true CN101962464B (en) | 2012-05-30 |
Family
ID=43515525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102923304A Expired - Fee Related CN101962464B (en) | 2010-09-27 | 2010-09-27 | Method for preparing calcium alginate microspheres with temperature response performance |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101962464B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191657B (en) * | 2013-04-02 | 2015-04-22 | 天津工业大学 | Hybridized gel film for filtration of organic solvent and preparation method thereof |
| CN103224633B (en) * | 2013-04-02 | 2014-11-19 | 天津工业大学 | Self-reinforced hybrid hydrogel used for artificial muscles and preparation method thereof |
| CN114377195A (en) * | 2021-12-30 | 2022-04-22 | 南京医科大学附属口腔医院 | Strontium alginate nano-microsphere and preparation method and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US523090A (en) * | 1894-07-17 | Fastener for sash meeting-rails | ||
| JP3589771B2 (en) * | 1996-01-24 | 2004-11-17 | 麒麟麦酒株式会社 | How to make alginate gel spheres |
| CN101265332A (en) * | 2008-03-18 | 2008-09-17 | 天津大学 | Macro molecule engram polyvinylpyrrolidone/calcium alginate polymer micro-sphere and preparation method thereof |
| CN101423564B (en) * | 2008-12-08 | 2011-05-04 | 青岛明月海藻集团有限公司 | Method for preparing alginate for fast preparation of hydrogel |
-
2010
- 2010-09-27 CN CN2010102923304A patent/CN101962464B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101962464A (en) | 2011-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liang et al. | Novel method using a temperature-sensitive polymer (methylcellulose) to thermally gel aqueous alginate as a pH-sensitive hydrogel | |
| CN103004757B (en) | Porous temperature-sensitive hydrogel slow release formulation and preparation method thereof | |
| CN102702539B (en) | A kind of preparation method for the hyaluronic acid micella that dopamine is modified | |
| CN103834045B (en) | A kind of bidirectional reversible thermosensitive hydrogel and preparation method thereof | |
| CN104530263A (en) | Preparation method of gallic acid-bagasse xylan ester | |
| CN105492595A (en) | Cell culture article and methods thereof | |
| CN101962464B (en) | Method for preparing calcium alginate microspheres with temperature response performance | |
| CN103751857A (en) | Drug-loaded silica embolism microsphere and preparation method thereof | |
| CN113429589B (en) | Glycyrrhetinic acid-based pH-sensitive slow-release hydrogel material and preparation method and application thereof | |
| CN102516578A (en) | Preparation method of crylic acid resin with high water absorbability | |
| CN110092948A (en) | Polyvinyl alcohol crosslinked hyaluronic acid derivatives and preparation method thereof | |
| CN103588924A (en) | Tea polyphenol-acrylic acid series super absorbent resin and preparation method thereof | |
| CN101045064A (en) | Gitamycin slow-release micro-ball preparation and its preparing process | |
| CN108478875A (en) | A kind of preparation method and applications of cross-linked hyaluronic acid gel microballoon | |
| CN109692634A (en) | A kind of micron polymeric particles and preparation method thereof based on eutectic solvent lotion | |
| CN104225614A (en) | Chitosan grafted polylactic acid composite microsphere simultaneously carried with hydrophilic and hydrophobic biological molecules and preparation method of chitosan grafted polylactic acid composite microsphere | |
| CN107522824A (en) | A kind of preparation method of protein/macromolecule composite aquogel microballoon | |
| Ma et al. | Experimental study on thermosensitive hydrogel used to extinguish class A fire | |
| CN102391429A (en) | PH-sensitive xylan hydrogel and preparation method thereof | |
| CN104725581A (en) | Method for preparing and applying light/temperature sensitive amphiphilic block polymer micelle | |
| CN102977223B (en) | Preparation method for anisic aldehyde-modified sodium alginate and gel microspheres thereof | |
| CN102659980B (en) | Method for preparing double hydrophilic thermo-sensitive polymer nano micelles | |
| Lanke et al. | Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system | |
| CN101450996A (en) | Glucose responding type polyphosphazene hydrogel and preparation method thereof | |
| Khames et al. | Preparation and in vitro characterization of glibenclamide-loaded alginate hexyl-amide beads: a novel drug delivery system to improve the dissolution rate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20110202 Assignee: QINGDAO FINEKING NEW MATERIALS CO.,LTD. Assignor: Qingdao University Contract record no.: 2013990000540 Denomination of invention: Method for preparing calcium alginate microspheres with temperature response performance Granted publication date: 20120530 License type: Exclusive License Record date: 20130829 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| EC01 | Cancellation of recordation of patent licensing contract | ||
| EC01 | Cancellation of recordation of patent licensing contract |
Assignee: QINGDAO FINEKING NEW MATERIALS CO.,LTD. Assignor: QINGDAO University Contract record no.: 2013990000540 Date of cancellation: 20220510 |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 |